Click to copy
Click to copy

Adma Biologics: 2Q Earnings Snapshot

August 8, 2019

RAMSEY, N.J. (AP) _ Adma Biologics Inc. (ADMA) on Thursday reported a loss of $13.2 million in its second quarter.

The Ramsey, New Jersey-based company said it had a loss of 25 cents per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 26 cents per share.

The infectious disease drug developer posted revenue of $6.6 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $4.4 million.

The company’s shares closed at $3.35. A year ago, they were trading at $6.25.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMA at https://www.zacks.com/ap/ADMA

All contents © copyright 2019 The Associated Press. All rights reserved.